VANESSA ZICKEFOOSE: Open Payments
NPI 1982205449 · GLENPOOL, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,964 in 217 payments from 17 companies in 2025. Trend: 2023 $3,022 · 2024 $3,665 · 2025 $5,964
Food & beverage: $4,224Consulting: $1,740
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 10 | $1,882 |
| Amgen Inc. | 72 | $1,124 |
| ABBVIE INC. | 33 | $610 |
| UCB, Inc. | 18 | $470 |
| AstraZeneca Pharmaceuticals LP | 19 | $467 |
| Mallinckrodt Hospital Products Inc. | 10 | $321 |
| E.R. Squibb & Sons, L.L.C. | 12 | $298 |
| Novartis Pharmaceuticals Corporation | 15 | $275 |
| PFIZER INC. | 9 | $139 |
| Fresenius Kabi USA, LLC | 5 | $89 |
Products named: TREMFYA, Bimzelx, SAPHNELO, ENBREL, RINVOQ, ACTHAR, ORENCIA, TAVNEOS.
Industry payments across OK — which companies pay providers there.
